Gregory Pennock
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 6
- Vascular Tumors and Angiosarcomas 2
-
- Immunotherapy and Immune Responses 4
- Phagocytosis and Immune Regulation 3
- Co-authors
- Laura Q.M. Chow (1 shared paper)Jedd D. Wolchok (1 shared paper)William Waterfield (1 shared paper)Patrick Schöffski (3 shared papers)Piotr Rutkowski (2 shared papers)Alby Elias (2 shared papers)Hagop Youssoufian (2 shared papers)Thierry Gil (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Journal of Thoracic Oncology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Gregory Pennock
20 papers receiving 519 citations
Peers
Comparison fields: 5 of 66
- Oncology 384
- Immunology 153
- Pulmonary and Respiratory Medicine 132
- Pathology and Forensic Medicine 48
- Otorhinolaryngology 11
Countries citing papers authored by Gregory Pennock
This map shows the geographic impact of Gregory Pennock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Pennock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Pennock more than expected).
Fields of papers citing papers by Gregory Pennock
This network shows the impact of papers produced by Gregory Pennock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Pennock. The network helps show where Gregory Pennock may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Pennock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 182 | |
| 2 | 2013 | 72 | |
| 3 | 2011 | 65 | |
| 4 | 2020 | 60 | |
| 5 | 2011 | 44 | |
| 6 | 2021 | 39 | |
| 7 | 2015 | 14 | |
| 8 | 2011 | 13 | |
| 9 | 2023 | 7 | |
| 10 | 2009 | 7 | |
| 11 | 2024 | 4 | |
| 12 | 2013 | 4 | |
| 13 | 2013 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2009 | 3 | |
| 16 | 2012 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2024 | 1 |
About Gregory Pennock
Gregory Pennock is a scholar working on Oncology, Immunology, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 527 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers), Sarcoma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers), Phagocytosis and Immune Regulation (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Oncology (384 citations), Immunology (153 citations), Pulmonary and Respiratory Medicine (132 citations), Pathology and Forensic Medicine (48 citations) and Otorhinolaryngology (11 citations). Gregory Pennock has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Laura Q.M. Chow, Jedd D. Wolchok, William Waterfield, Patrick Schöffski, Piotr Rutkowski, Alby Elias, Hagop Youssoufian, Thierry Gil, Jean‐Yves Blay and Hans Gelderblom. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.